CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Maria Lee, Yumi Lee, Kidong Kim, Eun Young Park, Myong Cheol Lim, Jung-Sup Kim, Hee Seung Kim, Yong-Beom Kim, Yong-Man Kim, Jungnam Joo, Sang Yoon Park, Chel Hun Choi, Jae-Hoon Kim
Cancer Research and Treatment. 2019;51(1):112-118.   Published online 2018 March 7    DOI: https://doi.org/10.4143/crt.2017.361

Excel Download

Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Cancer Research and Treatment. 2019;51(1):112-118   Crossref logo
Link1 Link2 Link3

Evaluation of pemetrexed in the treatment of epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: a retrospective study
. 2020;   Crossref logo
Link1 Link2

Outpatient Intraperitoneal Chemotherapy for All Stages of Ovarian, Fallopian Tube, and Peritoneal Cancers: A Pilot Study
Clinical Ovarian Cancer. 2011;4(1):7-11   Crossref logo
Link1 Link2

Evaluation of three predictive models assessing debulkability of patients with advanced ovarian, fallopian tube, or primary peritoneal cancer
Gynecologic Oncology. 2015;137(3):597-598   Crossref logo
Link1 Link2

Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
Gynecologic Oncology. 2010;116(3):364-369   Crossref logo
Link1 Link2

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series
Gynecologic Oncology. 2010;117(2):330-335   Crossref logo
Link1 Link2

Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
BioDrugs. 2013;27(4):375-392   Crossref logo
Link1 Link2 Link3

Referrals to Genetic Counseling in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, an Institutional Review
Gynecologic Oncology. 2015;139(3):586   Crossref logo
Link1 Link2

Thromboembolic events post cytoreductive surgery in patients with ovarian, fallopian tube or primary peritoneal cancer
Gynecologic Oncology. 2020;159:148   Crossref logo
Link1 Link2

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Yearbook of Medicine. 2011;2011:156-157   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.